Skip to main content
Daily Report

Daily Cosmetic Research Analysis

03/20/2026
3 papers selected
20 analyzed

Analyzed 20 papers and selected 3 impactful papers.

Summary

Three studies stood out today in cosmetic and aesthetic medicine: a paired sampling study shows skin tissue specimens capture a broader, deeper-layer mycobiome than swabs; a split-face clinical study demonstrates a fibronectin-containing serum expedites skin barrier recovery after IPL; and a large retrospective series supports exclusive fat grafting as an effective, low-complication strategy for tuberous breast correction.

Research Themes

  • Skin microbiome sampling methods and diagnostic implications
  • Post-procedural barrier repair in energy-based aesthetic treatments
  • Autologous fat grafting as definitive correction for congenital breast deformity

Selected Articles

1. Exploring the Skin Mycobiome: A Comparison of Skin Swabs and Tissue Specimens.

64.5Level IIICohort
Aesthetic plastic surgery · 2026PMID: 41857162

Paired ITS rRNA sequencing showed tissue specimens harbor greater fungal diversity than surface swabs and better detect non-Malassezia taxa. Malassezia predominates on swabs, while Trichoderma is enriched in tissue, indicating sampling depth strongly shapes observed mycobiome.

Impact: This work clarifies how sampling method biases skin mycobiome profiles, providing an evidence base to choose surface swabs versus tissue biopsies depending on clinical and research questions.

Clinical Implications: Use swabs for surface-dwelling Malassezia-focused questions; obtain tissue when deeper fungi or non-Malassezia detection is needed (e.g., suspected invasive or systemic involvement), to improve diagnostic yield and study design.

Key Findings

  • Tissue specimens showed higher fungal diversity than swabs (Chao1 P=0.028; Shannon P=0.0136).
  • Malassezia abundance was higher in swabs (P=0.002), whereas Trichoderma was more prevalent in tissue (P=0.0001).
  • Tissue sampling demonstrated superior sensitivity for detecting non-Malassezia species compared with swabs.

Methodological Strengths

  • Paired within-individual sampling minimized inter-subject variability.
  • Next-generation ITS rRNA gene sequencing with diversity metrics and statistical testing.

Limitations

  • Sample size and participant demographics were not specified in the abstract.
  • Clinical outcome correlations and feasibility of routine tissue sampling were not assessed.

Future Directions: Standardize skin mycobiome sampling protocols by indication; validate findings across diseases and body sites; integrate host immune profiling to link sampling depth with clinical outcomes.

Recent research has underscored the significant role of skin fungi in human health and disease. The advent of next-generation sequencing has facilitated the identification of previously unrecognized fungi; however, a standardized sampling method for the skin mycobiome has yet to be established. Given that fungi are distributed across all layers of the skin, this study aimed to establish and compare the fungal profiles obtained from paired skin swabs (skin surface) and tissue specimens (skin dermis), utilizing ITS rRNA gene sequencing. Fungal diversity and composition varied between swabs and tissue specimens from the same individual. Tissue specimens exhibited greater fungal diversity relative to skin swabs, as indicated by the Chao1 estimator (P=0.028) and Shannon index (P=0.0136). Notably, Malassezia species was more abundant in swabs (P=0.002), whereas Trichoderma species was more prevalent in tissue samples (P=0.0001). Compared to swabs, tissue sampling also demonstrated superior sensitivity in detecting non-Malassezia species. These findings suggest that skin swabs and tissue specimens provide different views of the skin mycobiome: Swabs are effective for studies targeting surface-dwelling fungi, while tissue sampling remains necessary when investigating deeper skin fungi and potential systemic infections. Future research should carefully consider appropriate sampling method based on target fungal location to mitigate procedural artifacts.Level of Evidence III This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

2. Fibronectin-Based Skin Care Regimens for Skin Recovery After Intense Pulsed Light Therapy: A Split-Face Study.

64Level IICohort
Clinical, cosmetic and investigational dermatology · 2026PMID: 41858601

In a 28-day split-face study (n=32 women), a fibronectin-containing serum significantly improved hydration and reduced TEWL on days 3, 7, and 28 versus control; radiance and erythema were also superior by days 7 and 28. No adverse events were reported, supporting its role in post-IPL care.

Impact: Provides controlled clinical evidence for a specific active (fibronectin) to accelerate barrier recovery and reduce erythema after IPL, addressing a common post-procedure need.

Clinical Implications: Consider incorporating a fibronectin-containing serum immediately after IPL to shorten downtime and improve patient comfort by enhancing hydration, reducing TEWL, and mitigating erythema.

Key Findings

  • Hydration increased significantly versus control (P<0.01).
  • TEWL was significantly lower at days 3 (P<0.05), 7 (P<0.01), and 28 (P<0.01) on the fibronectin-treated side.
  • Radiance and erythema improved more on days 7 and 28 (P<0.01); no adverse events occurred.

Methodological Strengths

  • Split-face, intra-individual controlled design minimizing confounding.
  • Multiple objective endpoints (hydration, TEWL, erythema, radiance) across several time points with clinician and participant assessments.

Limitations

  • Small, female-only sample limits generalizability.
  • Randomization and blinding procedures were not described; follow-up limited to 28 days.

Future Directions: Conduct larger randomized, blinded trials with longer follow-up to confirm durability and explore mechanisms of fibronectin-mediated barrier repair.

PURPOSE: Intense pulsed light (IPL) treatment may cause transient erythema, dryness, and barrier dysfunction, highlighting the need for effective postprocedural care. This study aimed to assess the efficacy and safety of a fibronectin-containing skincare regimen in restoring skin barrier function and relieving these IPL-related manifestations. PATIENTS AND METHODS: In this 28-day, split-face study, 32 healthy female participants undergoing IPL treatment applied a fibronectin-containing serum to one side of the face and a control serum to the opposite side. Skin hydration, transepidermal water loss (TEWL), erythema, and radiance were evaluated at baseline, immediately post-IPL, and on days 3, 7, and 28. RESULTS: Compared to the control, the fibronectin-treated side showed significantly greater improvements in skin hydration (P < 0.01) and significantly lower TEWL on days 3 (P < 0.05), 7 (P < 0.01), and 28 (P < 0.01). By days 7 and 28, skin radiance and erythema also improved more significantly (P < 0.01). Both dermatologist and participant assessments confirmed the superior efficacy of the fibronectin serum. No adverse events were rePorted. CONCLUSION: Post-IPL aPPlication of a fibronectin-containing serum effectively imProves skin hydration, reduces barrier dysfunction and erythema, and enhances radiance with good tolerability. These findings suPPort its Potential utility in Post-IPL skincare regimens.

3. Management of Tuberous Breasts by Exclusive Fat Grafting.

63.5Level IIICase series
Aesthetic plastic surgery · 2026PMID: 41857161

In 81 patients (103 breasts), exclusive fat grafting for tuberous breasts required a median of two sessions, had a 3% rate of cystic fat necrosis (one surgical intervention), and achieved 90.9% patient satisfaction, independent of deformity stage. Authors position the technique as their gold standard.

Impact: A relatively large, focused series suggests exclusive fat grafting can reliably correct tuberous breast deformity with low morbidity and high satisfaction, potentially reducing reliance on implants.

Clinical Implications: Offer staged exclusive fat grafting to eligible tuberous breast patients (with appropriate oncologic screening), setting expectations for multiple sessions and monitoring for cystic fat necrosis.

Key Findings

  • Retrospective series of 81 patients (103 breasts) with a median of two fat grafting sessions.
  • Complications were limited to cystic fat necrosis in 3% of breasts (n=3), with only one requiring surgical fragmentation.
  • Overall satisfaction was high (90.9% satisfied or very satisfied), not correlated with tuberous breast stage.

Methodological Strengths

  • Relatively large single-technique cohort for a specific deformity.
  • Standardized inclusion (no personal/family breast cancer; recent mammogram ACR 1–2) and use of BREAST-Q-based satisfaction assessment.

Limitations

  • Retrospective, uncontrolled design with potential selection bias.
  • Objective volumetric retention and long-term outcomes were not detailed.

Future Directions: Prospective comparative trials versus glandular remodeling/implant-based approaches; quantify long-term volume retention and patient-reported outcomes.

INTRODUCTION: Tuberous breast is a congenital breast deformity that can have a significant impact. Most therapeutic algorithms involve glandular remodeling, with or without the addition of a breast implant. The increased use of fat grafting in breast surgery has introduced a new tool in the surgical arsenal. We conducted a retrospective study. The primary objective was to evaluate our surgical technique. The secondary objective was to assess patient satisfaction in a larger cohort than previously studied. MATERIALS AND METHODS: This retrospective study included patients operated for unilateral or bilateral breast deformities. The fat grafting technique was offered to patients without any personal or familial history of breast cancer and with a mammogram performed within six months rated ACR 1 or 2. Patient satisfaction was retrospectively assessed at a minimum of 6 months post-op using the Breast-Q® augmentation module and an analog scale rated from 1 to 4. RESULTS AND DISCUSSION: Statistical analysis was conducted on the 81 patients (103 breasts) included in the study. The median was two interventions. The only complication found was cystic fat necrosis cysts in 3% of breasts (n=3), with only one requiring surgical fragmentation. Patient evaluation was not correlated with the stage of the tuberous breast. According to our satisfaction scale, 90.9% of patients were satisfied or very satisfied with the overall appearance of their breasts. CONCLUSION: Fat grafting should not be considered merely as a volume augmentation but as a true reactivation of breast growth, akin to a localized pubertal restart of an underdeveloped breast. The quality of results obtained, the very high level of patient satisfaction, the very low complication rate, and the definitive nature of the reconstruction have made this technique our Gold Standard for managing tuberous breasts. LEVEL OF EVIDENCE III: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .